FOXP3 and biliary tract cancer: The antibody reacting with the N-terminus of Foxp3 highlighted carcinoma cells and Treg cells in 39% of biliary tract cancers while the antibody reacting with the C-terminus of Foxp3 detects only the mononuclear cells that correspond to Treg cells (Figure 4(b)).